Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,402 | 0,426 | 07:55 | |
0,404 | 0,426 | 07:41 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | ADVANCE ZINCTEK LIMITED: Business Update | - | ASX | ||
15.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
14.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
11.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
09.04. | ADVANCE ZINCTEK LIMITED: Application for quotation of securities - ANO | - | ASX | ||
ADVANCE ZINCTEK Aktie jetzt für 0€ handeln | |||||
09.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
08.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
07.04. | ADVANCE ZINCTEK LIMITED: Further Update on Tariffs | - | ASX | ||
04.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
02.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 1 | ASX | ||
01.04. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 2 | ASX | ||
26.03. | ADVANCE ZINCTEK LIMITED: Business Update | 1 | ASX | ||
17.03. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | 2 | ASX | ||
26.02. | ADVANCE ZINCTEK LIMITED: Application for quotation of securities - ANO | 1 | ASX | ||
25.02. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
19.02. | ADVANCE ZINCTEK LIMITED: Half Yearly Report and Accounts | 2 | ASX | ||
19.02. | ADVANCE ZINCTEK LIMITED: Appendix 4D | 3 | ASX | ||
19.02. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
18.02. | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | - | ASX | ||
18.02. | ADVANCE ZINCTEK LIMITED: Market Update | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 22,750 | +0,44 % | Aktienmarkt: Formycon-Aktie kann sich nicht behaupten (22,45 €) | Im Minus liegt aktuell die Aktie von Formycon . Zuletzt zahlten Investoren für das Papier 22,45 Euro. Ein Minus in Höhe von 60 Cent müssen derzeit die Aktionäre von Formycon hinnehmen. Die Aktie wird... ► Artikel lesen | |
KOPIN | 1,020 | -2,02 % | Kopin Wins U.S. Army Contract To Define MicroLED Standards For XR Warfighter Displays | WASHINGTON (dpa-AFX) - Kopin Corporation (KOPN), a specialist in high-performance microdisplays and optical systems, Thursday announced that it has secured a significant contract with the U.S.... ► Artikel lesen | |
GAUZY | 10,130 | +4,87 % | Gauzy in Reverse Despite Mercedes-Benz Link | ||
ONTO INNOVATION | 110,00 | -0,90 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
VEECO INSTRUMENTS | 16,900 | 0,00 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
ZENTEK | 1,060 | 0,00 % | Zentek Ltd.: Zentek Provides Update on ~$1.1 Million Innovative Solutions Canada Contract to Develop an Avian Influenza Countermeasure Using its Multivalent Aptamer Technology | GUELPH, ON / ACCESS Newswire / April 23, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), is pleased to announce that it has completed the first phase of the Innovative Solutions... ► Artikel lesen | |
DOTZ NANO | 0,041 | -2,38 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
SOLESENCE | 2,480 | 0,00 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
NVE | 50,000 | -1,96 % | NVE Corporation (NVEC): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | ||
OBDUCAT | 0,043 | -10,42 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
ACACIA RESEARCH | 2,560 | -3,76 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
LEHNER INVESTMENTS | 0,032 | 0,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 0,880 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
RIBER | 2,320 | +0,87 % | RIBER reports solid growth in sales and earnings in 2024 | RIBER reports solid growth in sales and earnings in 2024 Revenues: €41.2m (+5%)Income from ordinary operations: €4.5m, representing 11% of revenues Net income: €4.1m (+21%)Proposed payout of €0.08... ► Artikel lesen | |
NANOVIRICIDES | 1,190 | 0,00 % | Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak | SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals... ► Artikel lesen |